There were no cases of glucose intolerance, insulin resistance, edema (fluid retention), joint pain, carpal tunnel syndrome, or other manifestations of excess growth hormone activity
For human therapeutic use, no
After treatment cessation at week 26, some weight regain was observed by the week 32 follow-up visit
Modeling experiments on work done with scrapie, Alzheimers, Parkinsons disease and others, exploring the propensity of transmitting pathology from human material to cells and animals engineered to be susceptible to such spread, would provide strong evidence for the proteopathic theory of MS
ongoing investigation into pharmacokinetics
If you appreciate ingredients designed for specific applications rather than general-purpose products, AHK-Cu fits that philosophy